Violeta Slavtchevska

TapImmune, Inc. (OTC:TPIV) Jumps Up Unexpectedly

by Violeta Slavtchevska Nov 21, 2011

Watch the video to learn about the probability of TapImmune, Inc. (TPIV) Chart Signal as of Apr 23 2014

This free program will calculate the probabilities of TapImmune, Inc. (TPIV) stock chart

Rating: Platform: Win/Mac
Price: FREE Version: 1.1
Size: 656KB Downloads:
FREE DOWNLOAD
On Friday TapImmune, Inc. (OTC:TPIV, TPIV message board) stock jumped up both in share price and trading volume. There is no direct explanation for now as the latest news from the company dates back to the beginning of the month and the new financials will come out with a delay. 6TPIV.png

TPIV closed the last trading session at $0.24, increasing 39.53% from the previous day close. The highest price during the day was $0.26, but the resistance for the past several months is $0.28.

the trading volume exceeded 1.5 million shares on Friday, which together with the technical set-up on the chart suggest that TPIV could jump up again today.

The last financial report of the company shows minor assets and large debts, as well as high dilution risks for shareholders coming from the fact that the company had an outstanding convertible note in an amount higher than $500,000. In addition, TPIV does not have any marketable products and is in a dire need to raise capital in order to continue its development activities and to pay out its current liabilities.7TapImmune.jpg

Not much better sounds the Notification of Late Filing concerning the quarter report for the period ending September 2011 which the company submitted on Monday last week. Otherwise, the latest optimistic news came through a press release in the beginning of the month. Then, TPIV announced a collaboration agreement with Nature Immunology and Arkitek Studios under which a 3D animation of the TAP mechanism should be created.

TAP is described as a protein pump located in the cells which plays an important role in TPIV current work on development of therapies for the treatment of cancer and of infectious diseases. Management believes it is working on a immune therapy that could be more effective than traditional cancer therapies, but it is yet very uncertain when, or if, its potential would be realized.

Watch the video to learn about the probability of TapImmune, Inc. (TPIV) Chart Signal as of Apr 23 2014

Hotstocked Precision will calculate the probabilities of TapImmune, Inc. (TPIV)

Rating:
Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads:
FREE DOWNLOAD

Comments (4)

1. e.brainy
November 22, 2011, 05:49AM

Quotes One of reasons was the shorters' interest. On Friday= 31.58%. Yesterday= 49.4%. The “influence” of the recent report is just to be seen.

2. spike.emy
November 22, 2011, 05:43AM

Quotes Violeta is right. Last Monday the company filled to the SEC the notification for the delayed financial reports . So, up to Friday, there was no news and … on Friday came the big bang of the share price.
Yesterday, days after the above bang TPIV disclosed its reports. As you may see, the stock price remained unchanged yesterday on turned heavy volume only.

3. Guest
November 21, 2011, 10:25AM

Quotes Then what is the reason?

4. Guest
November 21, 2011, 09:48AM

Quotes You should have had more information!!! This was not unexpected!!! There was a reason, please inform yourself before you publish something!!!

Type the characters that you see in the box (5 characters).

This is a captcha-picture.